Integra Lifesciences Holdings (IART) Gross Margin (2009 - 2026)
Integra Lifesciences Holdings recorded quarterly Gross Margin of 55.36% in Q1 2026, up 9.02% quarter-over-quarter from 50.78% in Q4 2025, and up 455.0% year-over-year from 9.98% in Q1 2025.
Integra Lifesciences Holdings' Gross Margin history runs 18 years deep, the most recent figure standing at 55.36% for Q1 2026.
- In Q1 2026, Gross Margin rose 455.0% year-over-year to 55.36%; the TTM figure through Mar 2026 stood at 51.94% (down 160.0% YoY), while the FY2025 annual figure was 50.86%, down 391.0% from the prior year.
- Gross Margin came in at 55.36% for Q1 2026 at Integra Lifesciences Holdings, up from 50.78% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 62.83% in Q4 2022 to a low of 50.37% in Q2 2025.
- A 5-year average of 56.26% and a median of 56.07% in 2024 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin tumbled 840 bps in 2023 and surged 455 bps in 2026, its largest moves.
- Integra Lifesciences Holdings' Gross Margin stood at 62.83% in 2022, then dropped by 9 bps to 57.05% in 2023, then fell by 1 bps to 56.27% in 2024, then slipped by 10 bps to 50.78% in 2025, then climbed by 9 bps to 55.36% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 55.36%, 50.78%, and 51.48% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn | 55.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.36% |
| Dec 31, 2025 | 50.78% |
| Sep 30, 2025 | 51.48% |
| Jun 30, 2025 | 50.37% |
| Mar 31, 2025 | 50.81% |
| Dec 31, 2024 | 56.27% |
| Sep 30, 2024 | 52.58% |
| Jun 30, 2024 | 54.02% |
| Mar 31, 2024 | 56.07% |
| Dec 31, 2023 | 57.05% |
| Sep 30, 2023 | 57.10% |
| Jun 30, 2023 | 54.30% |
| Mar 31, 2023 | 61.15% |
| Dec 31, 2022 | 62.83% |
| Sep 30, 2022 | 61.46% |
| Jun 30, 2022 | 62.70% |
| Mar 31, 2022 | 62.15% |
| Dec 31, 2021 | 61.47% |
| Sep 30, 2021 | 62.66% |
| Jun 30, 2021 | 61.21% |
| Mar 31, 2021 | 59.50% |
| Dec 31, 2020 | 62.16% |
| Sep 30, 2020 | 63.59% |
| Jun 30, 2020 | 59.22% |
| Mar 31, 2020 | 62.33% |
| Dec 31, 2019 | 62.17% |
| Sep 30, 2019 | 62.37% |
| Jun 30, 2019 | 62.55% |
| Mar 31, 2019 | 64.16% |
| Dec 31, 2018 | 61.79% |
| Sep 30, 2018 | 60.85% |
| Jun 30, 2018 | 62.43% |
| Mar 31, 2018 | 59.61% |
| Dec 31, 2017 | 59.80% |
| Sep 30, 2017 | 63.51% |
| Jun 30, 2017 | 64.91% |
| Mar 31, 2017 | 66.52% |
| Dec 31, 2016 | 66.59% |
| Sep 30, 2016 | 64.32% |
| Jun 30, 2016 | 64.07% |
| Mar 31, 2016 | 64.20% |
| Dec 31, 2015 | 62.68% |
| Sep 30, 2015 | 61.98% |
| Jun 30, 2015 | 64.62% |
| Mar 31, 2015 | 62.86% |
| Dec 31, 2014 | 61.19% |
| Sep 30, 2014 | 62.59% |
| Jun 30, 2014 | 55.86% |
| Mar 31, 2014 | 55.00% |
| Dec 31, 2013 | 83.54% |
| Sep 30, 2013 | 61.66% |
| Jun 30, 2013 | 60.19% |
| Mar 31, 2013 | 59.52% |
| Dec 31, 2012 | 61.79% |
| Sep 30, 2012 | 62.14% |
| Jun 30, 2012 | 62.76% |
| Mar 31, 2012 | 61.94% |
| Dec 31, 2011 | 59.35% |
| Sep 30, 2011 | 61.10% |
| Jun 30, 2011 | 71.45% |
| Mar 31, 2011 | 78.24% |
| Dec 31, 2010 | 63.27% |
| Sep 30, 2010 | 62.93% |
| Jun 30, 2010 | 63.90% |
| Mar 31, 2010 | 63.39% |
| Dec 31, 2009 | 65.16% |
| Sep 30, 2009 | 63.42% |
| Jun 30, 2009 | 63.91% |